Skip to content

AdaptHealth AHCO Sleep Health — Goodwill impairment (note 7)

Other segment segments

Diabetes Health
$128M
Respiratory Health
$0
Wellness at Home
$0

Similar metrics at other companies

Fox Factory Holding Corp. logo
FOXFGoodwill impairment
$139.33M
Bausch Health Companies logo
BHCGoodwill impairments
$1.43B
Perrigo Company logo
PRGOSelf Care — Goodwill impairment charge
$0
Driven Brands Holdings Inc. logo
DRVNGoodwill impairment
$7.08M
Bausch Health Companies logo
BHCGoodwill impairments
$1.43B
Harmonic logo
HLITGoodwill Impairment
$14.38M

Other financials

Income statement

See full
Revenue$819.8M+5.4%
Gross profit$111.5M-7.4%
Operating income$5.5M-76.3%
Net income-$16.0M-123%
EPS (diluted)-$0.12-140%

Balance sheet

See full
Cash & equivalents$48.0M-10.6%
Total debt$2.0B-4.9%
Total equity$1.5B-3.9%
Total assets$4.4B-0.3%

Cash flow

See full
Operating cash flow$93.7M-1.9%
CapEx$121.2M+26.8%
Free cash flow-$27.5M-47,297%

Valuation

See full
Market cap$1.36B+20.5%
Enterprise value$3.32B+4.3%
P/S0.4×+0.1×

Profitability

See full
Gross margin18.3%-1.6pp
Operating margin8%+6.9pp
Net margin-2.4%-5.1pp
FCF margin5.8%-2.6pp

Returns & leverage

See full
Return on equity-5.2%-10.8pp
Debt / equity1.3×0.0×
Current ratio0.9×-0.4×

Where this comes from

Reported directly by AdaptHealth in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.

The official record: AdaptHealth’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about AdaptHealth's sleep health — goodwill impairment (note 7).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AdaptHealth's sleep health — goodwill impairment (note 7)?
AdaptHealth (AHCO) reported sleep health — goodwill impairment (note 7) of $0 in Q4 2025.
What does sleep health — goodwill impairment (note 7) mean?
This metric represents a non-cash charge taken when the carrying value of goodwill within the sleep health segment exceeds its implied fair value. It signals that the expected future economic benefits of previous acquisitions in this segment have declined, often due to market changes or operational underperformance. Investors monitor this to assess the quality of past capital allocation decisions and the long-term viability of the segment's growth strategy.